Results 181 to 190 of about 5,105,474 (332)

ENGINEERING DEVELOPMENT OF FLUID-BED FLUORIDE VOLATILITY PROCESSES. PART 14. PROCESSING EXPERIENCE IN FLUORINATING PLUTONIUM MATERIALS AND THERMALLY DECOMPOSING PLUTONIUM HEXAFLUORIDE IN THE ENGINEERING-SCALE ALPHA FACILITY.

, 1969
N.M. Levitz, G.J. Vogel, E.L. Carls
openalex   +2 more sources

Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation

Molecular Oncology, EarlyView.
Cyclin D1 overexpression altered the cell adhesion pathway, while cyclin D2 upregulation had less impact on pathway enrichment analysis. Multiple myeloma (MM) patients with cyclin D1 overexpression showed reduced CD56 expression and increased circulating tumor cells (CTC) levels, suggesting that cyclin D1 may contribute to MM cell dissemination ...
Ignacio J. Cardona‐Benavides, Sara Cristobal‐Vargas, Cristina De Ramón, Elizabeta A. Rojas, Irena Misiewicz‐Krzeminska, Isabel Isidro, José Juan Pérez, Bruno Paiva, Noemi Puig, Miguel Alcoceba, María‐Victoria Mateos, Luis A. Corchete, Myriam Cuadrado, Norma C. Gutiérrez   +13 more
wiley   +1 more source

Engineering study: Improved facilities for the removal of Iodine-131 from Purex process vent off-gas

, 1962
Leandro Michels, L.L. Zahn
openalex   +2 more sources

Comprehensive profiling of lncRNAs and mRNAs enriched in small extracellular vesicles for early noninvasive detection of colorectal cancer: diagnostic panel assembly and extensive validation

Molecular Oncology, EarlyView.
Small extracellular vesicles are a promising source of diagnostic molecules. We conducted a comprehensive study, including transcriptome profiling and RT‐qPCR validation on large cohorts of samples. Diagnostic panels enabling sensitive detection of colorectal cancer and precancerous lesions were established. Some molecules were differentially expressed
Petra Vychytilova‐Faltejskova, Marketa Pavlikova, Lucie Pifkova, Robin Jugas, Tana Machackova, Lenka Radova, Milana Sachlova, Renata Bartosova, Tetiana Samoilenko, Zuzana Feckova, Jana Orlickova, Erika Slamova, Elleni Ponechal Michu, Dagmar Al Tukmachi, Michaela Ruckova, Martina Vodinska, Jan Kotoucek, Tina Catela Ivkovic, Marie Boudna, Lucia Bohovicova, Teodor Stanek, Jana Halamkova, Martin Svoboda, Vladimir Prochazka, Tomas Grolich, Zdenek Kala, Ondrej Slaby   +26 more
wiley   +1 more source

Research on the evaluation method of whole process engineering consulting service modes based on uncertain multiple-attribute group decision-making. [PDF]

Heliyon
Wang X, Hou Y, Peng J, Hu J.
europepmc   +1 more source

Process engineering of pH tolerant Ustilago cynodontis for efficient itaconic acid production. [PDF]

Microb Cell Fact, 2019
Hosseinpour Tehrani H, Saur K, Tharmasothirajan A, Blank LM, Wierckx N.   +4 more
europepmc   +1 more source

The critical role of DNA damage‐inducible transcript 4 (DDIT4) in stemness character of leukemia cells and leukemia initiation

Molecular Oncology, EarlyView.
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li, Zhijie Cao, Haiyan Xing, Zhenya Xue, Wenbing Liu, Jiayuan Chen, Yihan Mei, Runxia Gu, Hui Wei, Shaowei Qiu, Min Wang, Qing Rao, Jianxiang Wang   +12 more
wiley   +1 more source

DEVELOPMENT OF METHODS FOR THE REFABRICATION OF EBR-II FUEL ELEMENTS. PART I. ENGINEERING CONSIDERATIONS FOR EBR-II FUEL REFABRICATION. PART II. DEVELOPMENT OF INJECTION CASTING METHODS AND EQUIPMENT. PART III. DEVELOPMENT OF FUEL PIN PROCESSING METHODS AND EQUIPMENT. PART IV. ASSEMBLY, WELDING, AND LEAK TESTING EBR-II FUEL RODS. PART V. DODIUM BONDING AND BOND TESTING EBR-II FU

, 1961
A.B. Shuck, J.E. Ayer, H.F. Jelinek, G.M. Iverson, N.J. Jr. Carson, S.B. Brak, T.C. Cameron, N.F. Hessler   +7 more
openalex   +2 more sources

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

Molecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi, Mirjam Balbisi, Simon Sugár, Lóránd Váncza, Eszter Regős, Ilona Kovalszky, Ibolya Laczó, Tünde Harkó, Gábor Kecskeméti, Zoltán Szabó, Judit Moldvay, László Drahos, Lilla Turiák   +12 more
wiley   +1 more source

Process Engineering Accelerating an Economic Industrialization Towards a Bio-Based World. [PDF]

Molecules, 2019
Uhlenbrock L, Ditz R, Strube J.
europepmc   +1 more source